Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Revenue

In the year 2024, Orient Pharma had annual revenue of 1.22B TWD with 37.41% growth. Orient Pharma had revenue of 602.98M in the half year ending June 30, 2024, with 104.34% growth.

• Revenue: 1.22B
• Revenue Growth: +37.41%
• P/S Ratio: 6.55
• Revenue / Employee: 7.07M
• Employees: 173
• Market Cap: 7.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%
Dec 31, 2020	412.01M	58.47M	16.54%